Figure 6.Comparison of CD80/CD163 monocytes subsets among classical, intermediate and non-classical monocytes in AMI patients and older CTR subjects. (A) Classical, (B) intermediate, (C) non-classical monocytes. AMI = 21 patients affected by AMI, older than 65 years. Old = 19 healthy subjects older than 65 years. Data are expressed as mean±SEM. *p<0.05.
